https://orcid.org/0000-0002-6591-4538
Figures & data
Figure 1. Flow chart of the diagram. SARS: severe acute respiratory syndrome; MERS: Middle East respiratory syndrome; COVID-19: novel coronavirus disease 2019.
Table 1. Summary of the characteristics of the enrolled studies.
Table 2. Summary of the characteristics of the enrolled studies in patients with ESKD.
Figure 2. Mortality risk of AKI in three types of coronavirus diseases compared with non-AKI. AKI: acute kidney injury; SARS: severe acute respiratory syndrome; MERS: Middle East respiratory syndrome; COVID-19: novel coronavirus disease 2019.
Figure 3. Mortality risk of urgent-start KRT use in three types of coronavirus diseases. Urgent-start KRT: urgent-start renal replacement therapy; MERS: Middle East respiratory syndrome; COVID-19: novel coronavirus disease 2019.
Figure 4. Mortality risk of non-dialytic preexisting CKD in three types of coronavirus diseases compared with non-CKD. CKD: chronic kidney disease; SARS: severe acute respiratory syndrome; MERS: Middle East respiratory syndrome; COVID-19: novel coronavirus disease 2019.
Figure 5. Mortality risk of preexisting ESKD in three types of coronavirus diseases compared with non-ESKD. ESKD: end-stage renal disease; SARS: severe acute respiratory syndrome; MERS: Middle East respiratory syndrome; COVID-19: novel coronavirus disease 2019.
